"Two-tier" fears as UK enforces NICE (UK National Institute for Clinical Excellence) recommendations
This article was originally published in Clinica
The government has announced measures to enforce the recommendations of the National Institute for Clinical Excellence (NICE). Under new statutory directions due to come into force on 1 January 2002, the NHS will have three months from the date of publication of each technology appraisal guidance to provide funding that supports clinical decisions based on them.
You may also be interested in...
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.
Indian drug makers appear confident of meeting both domestic and global requirements for hydroxychloroquine sulphate after India relaxed export curbs on the product, subject to strict monitoring, against the backdrop of requests from global heads of government for supplies of the potential treatment for COVID-19.
CEO breaks down to Scrip how the Hong Kong-based company managed its way through the coronavirus outbreak in China, saying improvisation was critical.